The History of Terrorism
Preview
Open in TheBrain
Pyrimethamine
Attachments
Pyrimethamine
Parents
Aminopyrimidines
Antimalarial agents
Chloroarenes
Gertrude B. Elion
Malaria Drugs
Medical controversies
Protozoal dihydrofolate reductase inhibitors
Rational Drug Design
World Health Organization essential medicines
Children
2015 In September 2015, Shkreli was widely criticized when Turing obtained the manufacturing license for the antiparasitic drug Daraprim and raised its price by a factor of 56 (from US$13.50 to $750 per pill).
Shkreli was charged and convicted in federal court on two counts of securities fraud and one count of conspiring to commit securities fraud, unrelated to the Daraprim controversy.